Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.

Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM.

Genome Biol. 2007;8(2):R27.

2.

Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects.

Smalheiser NR, Lugli G, Zhang H, Rizavi H, Cook EH, Dwivedi Y.

PLoS One. 2014 Jan 27;9(1):e86469. doi: 10.1371/journal.pone.0086469. eCollection 2014.

3.

MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders.

Kim AH, Reimers M, Maher B, Williamson V, McMichael O, McClay JL, van den Oord EJ, Riley BP, Kendler KS, Vladimirov VI.

Schizophr Res. 2010 Dec;124(1-3):183-91. doi: 10.1016/j.schres.2010.07.002. Epub 2010 Aug 2.

4.

Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia.

Santarelli DM, Beveridge NJ, Tooney PA, Cairns MJ.

Biol Psychiatry. 2011 Jan 15;69(2):180-7. doi: 10.1016/j.biopsych.2010.09.030. Epub 2010 Dec 15.

PMID:
21111402
5.

MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects.

Smalheiser NR, Lugli G, Rizavi HS, Torvik VI, Turecki G, Dwivedi Y.

PLoS One. 2012;7(3):e33201. doi: 10.1371/journal.pone.0033201. Epub 2012 Mar 9.

6.

Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients.

Banigan MG, Kao PF, Kozubek JA, Winslow AR, Medina J, Costa J, Schmitt A, Schneider A, Cabral H, Cagsal-Getkin O, Vanderburg CR, Delalle I.

PLoS One. 2013;8(1):e48814. doi: 10.1371/journal.pone.0048814. Epub 2013 Jan 30.

7.

Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder.

Moreau MP, Bruse SE, David-Rus R, Buyske S, Brzustowicz LM.

Biol Psychiatry. 2011 Jan 15;69(2):188-93. doi: 10.1016/j.biopsych.2010.09.039.

8.

CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.

Kunii Y, Zhang W, Xu Q, Hyde TM, McFadden W, Shin JH, Deep-Soboslay A, Ye T, Li C, Kleinman JE, Wang KH, Lipska BK.

Am J Psychiatry. 2015 Nov 1;172(11):1122-30. doi: 10.1176/appi.ajp.2015.14080978. Epub 2015 Jul 24.

PMID:
26206074
9.

Maturation of the human dorsolateral prefrontal cortex coincides with a dynamic shift in microRNA expression.

Beveridge NJ, Santarelli DM, Wang X, Tooney PA, Webster MJ, Weickert CS, Cairns MJ.

Schizophr Bull. 2014 Mar;40(2):399-409. doi: 10.1093/schbul/sbs198. Epub 2013 Jan 31.

10.

Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells.

Gardiner E, Beveridge NJ, Wu JQ, Carr V, Scott RJ, Tooney PA, Cairns MJ.

Mol Psychiatry. 2012 Jul;17(8):827-40. doi: 10.1038/mp.2011.78. Epub 2011 Jul 5.

11.

Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study.

Keshavan MS, Stanley JA, Montrose DM, Minshew NJ, Pettegrew JW.

Mol Psychiatry. 2003 Mar;8(3):316-23, 251.

PMID:
12660804
12.

Expression of NPAS3 in the human cortex and evidence of its posttranscriptional regulation by miR-17 during development, with implications for schizophrenia.

Wong J, Duncan CE, Beveridge NJ, Webster MJ, Cairns MJ, Weickert CS.

Schizophr Bull. 2013 Mar;39(2):396-406. doi: 10.1093/schbul/sbr177. Epub 2012 Jan 6.

13.

In vivo microRNA detection and quantitation in cerebrospinal fluid.

Gallego JA, Gordon ML, Claycomb K, Bhatt M, Lencz T, Malhotra AK.

J Mol Neurosci. 2012 Jun;47(2):243-8. doi: 10.1007/s12031-012-9731-7. Epub 2012 Mar 9.

14.

MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del.

Zhao D, Lin M, Chen J, Pedrosa E, Hrabovsky A, Fourcade HM, Zheng D, Lachman HM.

PLoS One. 2015 Jul 14;10(7):e0132387. doi: 10.1371/journal.pone.0132387. eCollection 2015.

15.

Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia.

Kimoto S, Glausier JR, Fish KN, Volk DW, Bazmi HH, Arion D, Datta D, Lewis DA.

Schizophr Bull. 2016 Mar;42(2):396-405. doi: 10.1093/schbul/sbv139. Epub 2015 Sep 30.

16.

Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.

Mellios N, Huang HS, Baker SP, Galdzicka M, Ginns E, Akbarian S.

Biol Psychiatry. 2009 Jun 15;65(12):1006-14. doi: 10.1016/j.biopsych.2008.11.019. Epub 2009 Jan 1.

PMID:
19121517
17.

Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder.

Bychkov ER, Ahmed MR, Gurevich VV, Benovic JL, Gurevich EV.

Neurobiol Dis. 2011 Nov;44(2):248-58. doi: 10.1016/j.nbd.2011.07.009. Epub 2011 Jul 20.

19.

Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia.

Akbarian S, Ruehl MG, Bliven E, Luiz LA, Peranelli AC, Baker SP, Roberts RC, Bunney WE Jr, Conley RC, Jones EG, Tamminga CA, Guo Y.

Arch Gen Psychiatry. 2005 Aug;62(8):829-40.

PMID:
16061760
20.

Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder.

Morris HM, Hashimoto T, Lewis DA.

Cereb Cortex. 2008 Jul;18(7):1575-87. doi: 10.1093/cercor/bhm186. Epub 2008 Jan 17.

Supplemental Content

Support Center